Skip to main content
Fig. 1 | Molecular Cancer

Fig. 1

From: Multi-cohort validation of Ascore: an anoikis-based prognostic signature for predicting disease progression and immunotherapy response in bladder cancer

Fig. 1

Flow chart of this study. The figure illustrates the experimental design and flow of this article. (Abbreviations: TCGA: The Cancer Genome Atlas; BLCA: Bladder Cancer; ECM: Extracellular Matrix; LASSO: Least Absolute Shrinkage and Selection Operator; DEGs: Differentially Expressed Genes; ICIs: Immune Checkpoint Inhibitors; TIME: Tumor Immune Microenvironment; TIDE: Tumor Immune Dysfunction and Exclusion; TMB: Tumor Mutation Burden; GSVA: Gene Set Variation Analysis; GEO: Gene Expression Omnibus; CTC: Circulating Tumor Cell; RC: Radical Cystectomy; FFPE: Formalin Fixation and Paraffin Embedding; IHC: Immunohistochemistry; IC: Immune Cell)

Back to article page

Molecular Cancer

ISSN: 1476-4598